#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuromyelitis optica spectrum disorder Urethral valves Kearns-Sayre syndrome Marginal zone lymphoma B precursor type acute leukaemia Hyperadrenocorticism Fibrosarcoma metastatic Piriformis syndrome Leukoencephalopathy Acute hepatic failure Bulbospinal muscular atrophy congenital Immunoglobulin G4 related disease Metabolic disorder B-cell small lymphocytic lymphoma recurrent Hypochondroplasia More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy Von Willebrand’s disease – Diagnostics Nodal marginal zone B-cell lymphoma – Diagnostics Congenital nephrogenic diabetes insipidus – Life with Disease X-linked lymphoproliferative syndrome – Basic Information Piriformis syndrome Haemophilia B without inhibitors – Treatment Undifferentiated sarcoma – Basic Information Angiosarcoma metastatic – Basic Information Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fosamprenavir Calcium Metolazone Specific Nucleic Acid Sna-Ebv Prilocaine Isosorbide Dinitrate Trametinib Dimethyl Sulfoxide 7-Ethyl-10-Hydroxycamptothecin XYLOMETAZOLINE HYDROCHLORIDE Risankizumab N-Acetylhistidine Omp12 Idarubicin Hydrochloride Nadunolimab Cisplatin Suxamethonium Chloride Ketamine Brivaracetam Zolbetuximab Gskvx000000009151 Naltrexone Hydrochloride More therapies…

    Learn about Your Condition

    Oedema Malignant fibrous histiocytoma Staphylococcal infection Hepatitis alcoholic Breast cancer recurrent Nasal sinus cancer Vascular graft thrombosis Small intestine adenocarcinoma Febrile neutropenia Sarcoma Endotracheal intubation Glomerulonephritis Brain neoplasm malignant Uterine cancer Ventricular extrasystoles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Krankenhaus Nordwest GmbH

Krankenhaus Nordwest GmbH

Steinbacher Hohl 2-26, Praunheim, Frankfurt, 60488, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Gemcitabine, Cisplatin, Trastuzumab, and Pembrolizumab for Untreated HER2-Positive Biliary Tract Cancer Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gallbladder cancer
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine Hydrochloride
    • Pembrolizumab
    Germany

  • Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nivolumab
    • Regorafenib
    • Relatlimab
    Austria Belgium Czechia France Germany Italy +4

  • Study on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Belgium France Germany The Netherlands Spain Sweden

  • Study on the Effectiveness and Safety of Lenvatinib, Pembrolizumab, and Chemotherapy for Patients with Advanced or Metastatic Gastroesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Calcium Folinate
    • Capecitabine
    Belgium France Germany Ireland Italy Poland +1

  • Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buserelin Acetate
    • Degarelix
    • Leuprorelin Acetate
    Austria Germany

  • Study of ZN-c3, Encorafenib, and Cetuximab for Adults with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Encorafenib
    • Azenosertib
    • Cetuximab
    Germany Hungary Italy Poland Spain

  • Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +5

  • Study Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Cisplatin
    Germany

  • Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    Belgium Czechia France Germany Italy The Netherlands +3

  • Study of DKN-01 and Tislelizumab with Chemotherapy for Adults with Advanced Gastric or Gastroesophageal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Adenocarcinoma gastric
    • Gastric cancer
    Investigated Drugs:
    • Sirexatamab
    • Capecitabine
    • Fluorouracil
    Germany
Previous Page
1 … 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!